PharmaTher Holdings Ltd.
PHRM
CNSX
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.14M | -1.09M | -1.07M | -1.08M | -1.59M |
| Total Depreciation and Amortization | -- | -- | 0.00 | 0.00 | 300.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.00K | 129.80K | 96.50K | 65.10K | 178.00K |
| Change in Net Operating Assets | 190.00K | 95.40K | 74.70K | -237.70K | -429.00K |
| Cash from Operations | -796.40K | -868.60K | -896.60K | -1.25M | -1.84M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Investing | -- | -- | 0.00 | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 250.00K | -- | 35.00K | 35.00K | 35.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 182.30K | -- | 25.70K | 25.70K | 25.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -614.20K | -868.60K | -870.90K | -1.23M | -1.81M |